Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 44
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 221

2. Perspectives for the Future: Promises of Gene and Cell Therapy

FORUM RHEIN-NECKAR 2022/2023, Mannheim, Almanya, 26 Kasım 2022, (Özet Bildiri)

3. An improved approach for generation of beta cell like insulin-producing cells from induced pluripotent stem cells

58th EASD Annual Meeting of the European Association for the Study of Diabetes, İsveç, 19 - 23 Eylül 2022, (Özet Bildiri)

16. Resistance in human foreskin fibroblasts against lipofectamine-aided transfection of CoMiP plasmids

ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, İspanya, 22 - 25 Ekim 2019, cilt.30, (Özet Bildiri) identifier

17. Beta Hücresi Benzeri İnsülin Üreten Hücre Oluşturulmasında Güçlendirici Mekanizmalar

Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2019, (Özet Bildiri)

18. HuR knockdown decreases membrane expression of DR5 and reduces apoptosis levels

Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy, Lausanne, İsviçre, 16 - 19 Ekim 2018, cilt.29, (Özet Bildiri) identifier

19. Kanserde Gen Tedavisi

V. Nadir Tümörler Sempozyumu, Türkiye, 23 - 25 Şubat 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

20. DR5'in hücre yüzeyi ifadesinde HuR ve Vps39'un rolü

15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 29 Ekim 2017, ss.94, (Özet Bildiri)

21. Diyabette Deneysel Gen ve Hücre Tedavisi: TRAIL’xxın Rolü ve Olası Terapötik Potansiyeli

5. Genetik ve Biyomühendislik Günleri, Türkiye, 11 - 12 Şubat 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

22. Adacık Transplantasyonu

52. Ulusal Diyabet Kongresi, Türkiye, 20 - 24 Nisan 2016

24. C57BL6 Farelerde Tip 2 Diyabet Olus turmak ic in Etkin BirYo ntem

XIV. ULUSAL TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Türkiye, 27 - 30 Ekim 2015, (Özet Bildiri)

25. PANKREATI K BETA HU CRE PROLI FERASYONU ve TRAIL MOLEKU LU

XIV. ULUSAL TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Türkiye, 27 - 30 Ekim 2015

26. ROLE AND THERAPEUTIC POTENTIAL OF TRAIL IN DIABETES

INTERNATIONAL ITU MOLECULAR BIOLOGY AND GENETICS STUDENT CONGRESS, 2 - 05 Ekim 2015

27. PANKREATİK ADACIK REDDİNİ ÖNLEYECEK YÖNTEMLER

51. ULUSAL DİYABET KONGRESİ, Türkiye, 22 Nisan - 26 Ekim 2015

34. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications

The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

36. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment

Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

37. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment

Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

38. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment

Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

39. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications

The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

43. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications

The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

44. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment

Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

45. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes

Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

46. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes

Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

47. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes

Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

48. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes

Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

49. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes

Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri) Sürdürülebilir Kalkınma

50. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes

Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri) Sürdürülebilir Kalkınma

51. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes

Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri) Sürdürülebilir Kalkınma

58. Generation of a cost effective and a practical animal model for Type 2 Diabetes

Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri) Sürdürülebilir Kalkınma

59. Generation of a cost effective and a practical animal model for Type 2 Diabetes

Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri) Sürdürülebilir Kalkınma

60. Generation of a cost effective and a practical animal model for Type 2 Diabetes

Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri) Sürdürülebilir Kalkınma

61. Diabetogenic response to streptozotocin varies among NOD and NOR mice

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

62. Generation of a cost effective and a practical animal model for Type 2 Diabetes

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

63. Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

64. Pancreatic acinar cells respond differentially to diabetic agents Streptozotocin and Cyclophosphamide

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

66. In vivo tracing of the most commonly used gene therapy vector

9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.128, (Özet Bildiri)

67. “In Vivo Fluorescence Tracing Of Xenogeneic Islet Graft Survival In Type 1 Diabetes

9th National Congress of Medical Genetics, İstanbul, Türkiye, 1 - 05 Aralık 2010, cilt.0, sa.0, ss.1-2, (Özet Bildiri) Sürdürülebilir Kalkınma

68. TRAIL profile of synoviocytes and peripheral blood lymphpcytes of rheumatoid arhtiris patients.

XVIII Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1358-1396, (Özet Bildiri)

69. In vivo fluorescence imaging of xenogeneic islet graft survival

18th Annual Congress of the European Society of Gene and Cell Therapy, Milan, İtalya, 22 - 25 Ekim 2010, ss.1451, (Tam Metin Bildiri)

70. In vivo fluorescence imaging of xenogeneic islet graft survival

18th Annual Congress of the European Society of Gene and Cell Therapy, Milan, İtalya, 22 - 25 Ekim 2010, ss.1451, (Tam Metin Bildiri)

71. TRAIL profile of synoviocytes and peripheral blood lymphpcytes of rheumatoid arhtiris patients.

XVIII Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1358-1396, (Özet Bildiri)

72. Endometrial hyperplasia features distinctive trail and trail receptor expression profiles

18th Annual Congress of the European Society of Gene and Cell Therapy, Milan, İtalya, 22 - 25 Ekim 2010, ss.1462-1463, (Özet Bildiri)

73. Distinctive expression profiles of trail and trail receptors in patients with endometrial carcinoma

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462, (Özet Bildiri) identifier

74. Spontaneous type 1 diabetes in NOD mice is related to an increase in DcR1 expression

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1447-1448, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

75. Trail profile of synoviocytes and peripheral blood lymphocytes of rheumatoid arthritis patients

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1448-1449, (Özet Bildiri) identifier

76. Endometrial hyperplasia features distinctive trail and trail receptor expression profiles

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462-1463, (Özet Bildiri) identifier

77. In vivo fluorescence imaging of xenogeneic islet graft survival

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1451, (Özet Bildiri) identifier

83. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats

17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

84. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats

17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

85. Tracing of the fate of allogeneic islet grafts via CCD camera

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479, (Özet Bildiri) identifier

86. In vivo fluorescence imaging as a method to assess pancreatic islet xenograft failure

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479, (Özet Bildiri) identifier

87. Alterations in TRAIL ligand and receptor expression profiles in CY-accelerated type 1 diabetes in NOD mice

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

88. Differential levels of TRAIL ligand and receptor expressions in STZ-induced T1 diabetes in non-obese diabetic (NOD) mice

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

89. Monitoring of systemic delivery of adenovirus mediated EGFP transgene expression in mice using fluorescence imaging

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1507, (Özet Bildiri) identifier

90. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats

Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471-1472, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

104. Prolonged normoglycemia in STZ-induced diabetic rats transplanted with Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) infected islets

16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1119-1120, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

105. In vivo imaging to detect the duration of adenovirus mediated EGFP transgene expression in allogeneic islet grafts

16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1121-1122, (Özet Bildiri) identifier

112. The success of rat islet isolation mainly relies on complete pancreas inflation

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.4, (Özet Bildiri)

115. The success of rat islet isolation mainly relies on complete pancreas inflation

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.4, (Özet Bildiri)

116. In vivo fluorescent imaging of adenovirus delivery of reporter gene expression for allogeneic islet transplantation

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.11, (Özet Bildiri)

118. In vivo fluorescent imaging of adenovirus delivery of reporter gene expression for allogeneic islet transplantation

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.11, (Özet Bildiri)

120. Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5, (Özet Bildiri) Sürdürülebilir Kalkınma

123. Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patients

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.3, (Özet Bildiri) Sürdürülebilir Kalkınma

125. The success of rat islet isolation mainly relies on complete pancreas inflation

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.4, (Özet Bildiri)

126. Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes

3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5, (Özet Bildiri) Sürdürülebilir Kalkınma

136. TRAILING from molecular diagnostics to prostate cancer gene therapy

XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33, (Özet Bildiri) Sürdürülebilir Kalkınma

140. Adenovirus vectors efficiently deliver TRAIL into pancreatic islets without generating cytotoxic effects

15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074, (Özet Bildiri) identifier

141. High endogenous TRAIL expression levels in human pancreas is correlated with increased cell death

15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074-1075, (Özet Bildiri) identifier

152. High endogenous TRAIL expression levels in human pancreas is correlated with increased cell death

XVth Annual Congress of the European Society of Gene and Cell Therapy, Roterrdam, Hollanda, 1 - 06 Ağustos 2007, ss.1074-1075, (Tam Metin Bildiri)

162. Small interference RNA technology targeting DcR2 sensitized advanced prostate carcinoma cells to adenovirus delivery of TRAIL

XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.103, (Tam Metin Bildiri)

163. Electroporation enhances the first generation adenovirus vector transgene delivery into pancreatic islets

XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.208, (Tam Metin Bildiri)

165. Novel gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis

XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.206, (Tam Metin Bildiri)

166. Small interference RNA technology targeting DcR2 sensitized advanced prostate carcinoma cells to adenovirus delivery of TRAIL

XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.103, (Tam Metin Bildiri)

167. Electroporation enhances the first generation adenovirus vector transgene delivery into pancreatic islets

XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.208, (Tam Metin Bildiri)

170. Differential expression of trail and its receptors in patients with prostate carcinoma

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133, (Özet Bildiri) identifier

171. Adenovirus delivery of TRAIL effectively destroys synoviocytes of patients with rheumatoid arthritis

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.134, (Özet Bildiri) identifier

172. A DCR2 siRNA approach defeats trail resistance in lung cancer cells

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

173. Adenovirus mediated TRAIL gene delivery as a model for the treatment of patients with diabetes

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.206, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

182. Adenovirus delivery of TRAIL effectively destroys synovial fibroblasts of patients with rheumatoid arthritis

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.75, (Tam Metin Bildiri)

184. A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.172, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

185. Surface TRAIL decoy receptor-4 expression constitutes a resistance to adenovirus delivery of TRAIL in MCF7 breast cancer cells

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.15, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

186. Testing the efficacy of an adenovirus mediated TRAIL gene delivery for the treatment of patients with osteoarthritis

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.78, (Tam Metin Bildiri)

187. Decoy receptor gene expression as a chief mechanism to govern TRAIL resistance in advanced prostate carcinoma

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.23, (Tam Metin Bildiri)

188. Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes

13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.74, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

195. A novel gene therapy model for patients with Rheumatoid Arthritis

Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.161, (Tam Metin Bildiri)

198. Therapeutic effect of recombinant adenovirus mediated TRAIL gene therapy method in Lung Cancer

12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.22, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

202. Resistance to Adenovirus mediated TRAIL gene therapy in breast cancer cells is eliminated by the expression of dominant negative IKKb

12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.20, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

204. Akciğer kanserinde recombinant adenovirus aracılı TRAİL gen tedavi metodunun terapötik etkisi

1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.128, (Özet Bildiri) Sürdürülebilir Kalkınma

205. Hücre içi anti-apoptotik yolun bloke edilmesi meme kanserini adenovirus aracılı TRAİL gen tedavi metoduna karşı duyarlı hale getirdi

1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.127, (Özet Bildiri) Sürdürülebilir Kalkınma

206. İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar

VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27, (Özet Bildiri) Sürdürülebilir Kalkınma

207. İleri ever meme kanserinin adenovirus aracılı TRAİL gen tedavi metoduna duyarlılaştırma yöntemleri

VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.4, (Özet Bildiri) Sürdürülebilir Kalkınma

208. İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar

VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27, (Özet Bildiri) Sürdürülebilir Kalkınma

210. Gene Expression of a Dominant Negative IKK-beta Mutant in the Liver Improves Survival in a Murine Model of Endotoxic Shock

11th Annual Congress of European Society of Gene Therapy, Edinburgh, Birleşik Krallık, 13 - 16 Kasım 2003, ss.269, (Özet Bildiri)

212. Gen tedavisinde güncel gelişmeler.

8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.2, (Özet Bildiri)

217. Antalya'da Beta-Talasemi ve Orak Hücreli Anemide Yapılan Moleküler Genetik Çalışmalar

V.Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Konya, Türkiye, 9 - 12 Ekim 2002, ss.70, (Tam Metin Bildiri)

220. Antalya'da Beta-Talasemi ve Orak Hücre Anemisinin Moleküler Genetik Analiz Sonuçları

III.Ulusal Pediatrik Hematoloji Kongresi, Ankara, Türkiye, 17 - 20 Ekim 2001, ss.97, (Tam Metin Bildiri)

221. Antalya çevresinde beta-talasemi ve orak hücre anemisinin RDBH yöntemi ile taranması

IV.Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, İzmir, Türkiye, 3 - 06 Mayıs 2000, ss.233, (Tam Metin Bildiri)
Kitaplar 7

1. Nörodejeneratif ve Nöromüsküler Hastalıklarda Gen Tedavisi

Tanıdan Tedaviye Nörogenetik, , Editör, Bayçınar Tıbbi Yayıncılık, ss.109-118, 2025

2. Gen Tedavisi: Araç ve Yöntemleri

Tanıdan Tedaviye Nörogeneik, , Editör, Bayçınar Tıbbi Yayıncılık, ss.53-63, 2025

3. Diyabette gen ve hücre tedavisi: TNF-İlişkili Apoptoz-İndükleyici Ligand (TRAIL) ve potansiyel uygulamaları

Tıbbi Genetik Özel Konular / Gen ve Hücre Tedavisinde Güncel Konular, Gülseren Bağcı, Editör, Türkiye Klinikleri, Antalya, ss.45-50, 2021

6. Diyabette Uyarılmış Pluripotent Kök Hücre (uPKH)Teknolojisi: Hastalık Modeli Olarak Potansiyeli veTerapötik Yaklaşımlardaki Yeri

Türkiye Klinikleri İmmünoloji Alerji - Özel Konular, Ali Osman Gürol, Editör, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), ss.1-8, 2019

7. Proteomiks ve Stratejileri

Tıbbi Genetik ve Klinik Uygulamaları, Dündar Munis, Editör, MGRUP Matbaacılık Kayseri, ss.577-588, 2016
Metrikler

Yayın

280

Yayın (WoS)

66

Yayın (Scopus)

34

Atıf (WoS)

887

H-İndeks (WoS)

20

Atıf (Scopus)

905

H-İndeks (Scopus)

20

Atıf (Scholar)

1475

H-İndeks (Scholar)

24

Atıf (Sobiad)

173

H-İndeks (Sobiad)

5

Proje

10

Tez Danışmanlığı

6

Açık Erişim

12
BM Sürdürülebilir Kalkınma Amaçları